Charcot-Marie-Tooth disease is a heterogenous disorder manifesting as both motor and sensory symptoms. It involves a spectrum of disorders arising from pathogenic variants in several genes encoding proteins that are expressed in myelin, gap junctions, and axonal structures within the peripheral nerves.

The Regentime partially differentiated stem cell treatment holds neuroprotective, regenerative, and anti-inflammatory properties. They secrete multiple neurotrophic factors and can intervene in the gene-protein mechanisms enabling neuroprotection and promoting neurogenesis.

The Regentime procedure for CMT requires a stay of 5 days in Lebanon, with prices ranging from 23,700 USD to 34,000 USD.